✦ LIBER ✦

Pharmacokinetics, N1-glucuronidation and N4-acetylation of sulfamethomidine in humans

✍ Scribed by Vree, T. B. ;Kolmer, E. W. J. Beneken ;Hekster, Y. A.

Publisher: Springer
Year: 1991
Tongue: Dutch
Weight: 867 KB
Volume: 13
Category: Article
ISSN: 1573-739X
DOI: 10.1007/bf01988875

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Pharmacokinetics, N1-glucuronidation and

Pharmacokinetics, N1-glucuronidation and N4-acetylation of sulfadimethoxine in man

✍ Vree, T. B. ;Beneken Kolmer, E. W. J. ;Martea, M. ;Bosch, R. ;Hekster, Y. A. ;Sh 📂 Article 📅 1990 🏛 Springer 🌐 Dutch ⚖ 948 KB

Pharmacokinetics of glucuronidation of p

Pharmacokinetics of glucuronidation of propranolol following oral administration in humans

✍ K. K. Midha; R. M. H. Roscoe; T. W. Wilson; J. K. Cooper; J. C. K. Loo; A. Ho-Ng 📂 Article 📅 1983 🏛 John Wiley and Sons 🌐 English ⚖ 336 KB 👁 2 views

## Abstract Pharmacokinetic and bioavailability parameters of propranolol were estimated in 10 healthy adult subjects after single oral doses of two commercial tablet formulations of propranolol hydrochloride (2 × 40 mg). Plasma concentrations of propranolol were determined by a high‐performance li

Enantioselective analysis of N-hydroxyme

Enantioselective analysis of N-hydroxymexiletine glucuronide in human plasma for pharmacokinetic studies

✍ Vera Lucia Lanchote; Verônica Jorge Santos; Evandro José Cesarino; Sônia Apareci 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 125 KB 👁 2 views

Enzymatic hydrolysis with ␤-glucuronidase/sulfatase was used for the enantioselective determination of N-hydroxymexiletine glucuronide in plasma for pharmacokinetic studies. N-Hydroxymexiletine glucuronide was determined as the quantity of mexiletine released by hydrolysis (difference between the en

Pharmacokinetics and acetylation of sulf

Pharmacokinetics and acetylation of sulfa-2-monomethoxine in humans

✍ Tom B. Vree; Eleonora W. J. Beneken Kolmer; Yechiel A. Hekster; Minoru Shimoda; 📂 Article 📅 1992 🏛 John Wiley and Sons 🌐 English ⚖ 604 KB

In humans sulfa-2-monomethoxine (S) is metabolized by N,-acetylation (39.9 f 8.0 per cent). After an oral dose, S is eliminated biphasically (t%, 5.2 f 1.6 h and 13.2 f 3.4h) which is similar in both fast and slow acetylators. The metabolite N,-acetylsulfa-2monomethoxine (N, ) is eliminated monophas

High pressure liquid chromatographic ana

High pressure liquid chromatographic analysis and preliminary pharmacokinetics of sulfaphenazole and its N2-glucuronide and N4-acetyl metabolites in plasma and urine of man

✍ Vree, T. B. ;Beneken Kolmer, E. W. J. ;Hekster, Y. A. 📂 Article 📅 1990 🏛 Springer 🌐 Dutch ⚖ 418 KB

Pharmacokinetics, acetylation-deacetylat

Pharmacokinetics, acetylation-deacetylation, renal clearance, and protein binding of sulphamerazine, N4-acetylsulphamerazine, and N4-trideuteroacetylsulphamerazine in ‘fast’ and ‘slow’ acetylators

✍ Tom B. Vree; Chiel A. Hekster; Margriet Baakman; Tom Janssen; Marijn Oosterbaan; 📂 Article 📅 1983 🏛 John Wiley and Sons 🌐 English ⚖ 825 KB

Sulphamerazine shows a clear acetylator phenotype. The half-life of elimination of sulphamerazine is 12 h in 'fast' and 24 h in 'slow' acetylators. N,-Acetylsulphamerazine is eliminated biphasically, characterized by half-lives of 5 and 12 h in 'fast' and 5 and 24 h in 'slow' acetylators. Protein b